Next 10 |
home / stock / impzy / impzy news
2024-04-09 16:26:07 ET More on Implanet S.A. Implanet reports Q4 revenue decline of 20% Y/Y Historical earnings data for Implanet S.A. Financial information for Implanet S.A. Read the full article on Seeking Alpha For further details see: IMPLANET...
2024-03-06 11:23:59 ET More on Implanet S.A. SPON ADS EACH REPR 0.05 ORD SHS Implanet reports Q4 revenue decline of 20% Y/Y Historical earnings data for Implanet S.A. SPON ADS EACH REPR 0.05 ORD SHS Financial information for Implanet S.A. SPON ADS EACH REPR 0.05 ORD ...
2024-01-16 01:46:42 ET More on Implanet S.A. Historical earnings data for Implanet S.A. Financial information for Implanet S.A. For further details see: Implanet reports Q4 revenue decline of 20% Y/Y
2023-04-11 05:10:50 ET French medical device maker Implanet ( OTC:IMPZY ) said that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance to its Squale anterior cervical cage. The Squale, from the OSD product portfolio, features a range of implan...
Implanet press release ( OTCPK:IMPZY ): Q2 Revenue of €2.1M (+32.9% Y/Y). At 30 June 2022, Implanet had cash of €0.5M. For further details see: Implanet reports Q2 results
Implanet S.A. (IMPZY): Q2 Revenue of €2.04M (+98.1% Y/Y)At June 30, 2021, Implanet had a cash position of €0.37M. Press Release For further details see: Implanet S.A. reports Q2 results
IMPLANET ([[IMPZY]]) signs a distribution contract in Germany with ulrich GmbH & Co. KG for its JAZZ implants and the OSD cervical plate.ulrich medical, a company based in Ulm, Germany, that develops, produces and markets innovative medical technologies, is a renowned speci...
Implanet S.A. (IMPZY): Q1 Revenue of €1.68M (+7.0% Y/Y)Sold 1,952 JAZZ units, an increase of +29% Y/Y.Press Release For further details see: Implanet S.A. reports Q1 results
Implanet ([[IMPZY]]) announces that it has obtained founding shareholders’ agreement to acquire a majority stake in Orthopaedic & Spine Development (“OSD”), which specializes in developing, manufacturing and marketing implants for spine surgery, valued at ...
Implanet S.A. (IMPZY): Q3 Revenue of €1.75M (+0.6% Y/Y)"Our direct activity, which accounts for 82% of Implanet’s business, recorded a significant rally of +12% in the third quarter of 2020," says CEO Ludovic Lastennet. Press Release For further details see: Impl...